These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diffuse panbronchiolitis, the first case reports in Thailand. Chantarotorn S; Palwatwichai A; Vattanathum A; Tantamacharik D J Med Assoc Thai; 1999 Aug; 82(8):833-8. PubMed ID: 10511794 [TBL] [Abstract][Full Text] [Related]
4. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Nagai H; Shishido H; Yoneda R; Yamaguchi E; Tamura A; Kurashima A Respiration; 1991; 58(3-4):145-9. PubMed ID: 1745845 [TBL] [Abstract][Full Text] [Related]
5. [Clinical effects of low-dose and long-term erythromycin in diffuse panbronchiolitis with chronic respiratory failure]. Ohno S; Sugiyama Y; Kitamura S Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1251-6. PubMed ID: 8271657 [TBL] [Abstract][Full Text] [Related]
6. Diffuse panbronchiolitis-The response and recurrence after erythromycin therapy. Chuang MC; Chou YT; Lin YC; Hsieh MJ; Tsai YH J Formos Med Assoc; 2016 Oct; 115(10):876-882. PubMed ID: 26705139 [TBL] [Abstract][Full Text] [Related]
7. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Mukae H; Hirota M; Kohno S; Komori K; Fukushima K; Hiratani K; Kadota J; Hara K Am Rev Respir Dis; 1993 Sep; 148(3):744-51. PubMed ID: 8103656 [TBL] [Abstract][Full Text] [Related]
8. [Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis]. Yamamoto M; Kondo A; Tamura M; Izumi T; Ina Y; Noda M Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1305-13. PubMed ID: 2273658 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis]. Sugiyama Y; Sugama Y; Takeuchi K; Kudoh S; Kitamura S Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1574-80. PubMed ID: 2077202 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of cases allowed to cease erythromycin therapy for diffuse panbronchiolitis--comparative study between patients with cessation of the therapy and patients continuing the therapy]. Shirai R; Abe K; Yoshinaga M; Ishimatsu Y; Matsubara Y; Kawakami K; Iida K; Fujii T; Kawamoto S; Kaseda M; Kadota J; Kohno S Kansenshogaku Zasshi; 1997 Nov; 71(11):1155-61. PubMed ID: 9455056 [TBL] [Abstract][Full Text] [Related]
11. [Diffuse panbronchiolitis in a child: case report and literature review]. Zhao SY; Peng Y; Zhou CJ; Jiao AX; Jiang ZF Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):504-7. PubMed ID: 17953806 [TBL] [Abstract][Full Text] [Related]
12. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Kadota J; Sakito O; Kohno S; Sawa H; Mukae H; Oda H; Kawakami K; Fukushima K; Hiratani K; Hara K Am Rev Respir Dis; 1993 Jan; 147(1):153-9. PubMed ID: 8420410 [TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase in alveolar macrophages from patients with diffuse panbronchiolitis. Morikawa T; Kadota JI; Kohno S; Kondo T Respiration; 2000; 67(5):546-51. PubMed ID: 11070461 [TBL] [Abstract][Full Text] [Related]
14. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803 [TBL] [Abstract][Full Text] [Related]
15. The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis. Park SJ; Lee YC; Rhee YK; Lee HB Biochem Biophys Res Commun; 2004 Nov; 324(1):114-7. PubMed ID: 15464990 [TBL] [Abstract][Full Text] [Related]
16. [Application of macrolides to diffuse panbronchiolitis]. Kudoh S Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():554-8. PubMed ID: 17455680 [No Abstract] [Full Text] [Related]
17. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis. Poletti V; Chilosi M; Trisolini R; Cancellieri A; Zompatori M; Lazzari Agli L; Boaron M; Schulte W; Theegarten D; Guzman J; Costabel U Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):62-8. PubMed ID: 12737282 [TBL] [Abstract][Full Text] [Related]
18. Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway. Weng D; Wu Q; Chen XQ; Du YK; Chen T; Li H; Tang DL; Li QH; Zhang Y; Lu LQ; Zhou NY; Song JC; Wang C; Li HP Biomed Pharmacother; 2019 Feb; 110():440-448. PubMed ID: 30530046 [TBL] [Abstract][Full Text] [Related]
19. Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease: similarities and differences. Hayakawa H; Sato A; Imokawa S; Todate A; Chida K; Suzuki K; Iwata M Intern Med; 1998 Jun; 37(6):504-8. PubMed ID: 9678682 [TBL] [Abstract][Full Text] [Related]
20. [A clinical study of the long-term therapeutic effects of low-dose erythromycin in diffuse panbronchiolitis--with special reference to changes in tumor-associated carbohydrate antigens in serum]. Mukae H; Komori K; Morikawa N; Sakito O; Oda H; Senju R; Fukushima K; Hiratani K; Kadota J; Hara K Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):802-7. PubMed ID: 1352834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]